drugset / Trial / NCT04893174
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
NaSequentialOpen-labelTreatment
Summary
The clinical study with UMC119-06-05 is designed to investigate the safety in patients with mild to moderate knee osteoarthritis (KOA). This will be a dose escalation, open label, single-center study in adult with mild to moderate knee osteoarthritis. UMC119-06-05 is ex vivo cultured human umbilical cord tissue-derived mesenchymal stem cells product which is intended for treatment of knee osteoarthritis.
Timeline
- Start
- 2022-09-15
- Primary completion
- 2024-09
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | — | Other |
| Background | Hyaluronic Acid | Other / unclassified | — | Other |